Neurocrine Biosciences
NBIX
#1290
Rank
S$18.57 B
Marketcap
$183.51
Share price
0.34%
Change (1 day)
14.18%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): S$0.86 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are S$2.24 Billion. In 2023 the company made an earning of S$0.48 Billion, an increase over its 2022 earnings that were of S$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.86 B78.13%
2023 S$0.48 B62.85%
2022 S$0.29 B73.74%
2021 S$0.17 B-8.82%
2020 S$0.18 B77.78%
2019 S$0.10 B49.83%
2018 S$70.96 M-142.57%
2017 -S$0.17 Billion-14.73%
2016 -S$0.2 Billion53.15%
2015 -S$0.13 Billion46.25%
2014 -S$87.29 Million29.66%
2013 -S$67.32 Million-3530.8%
2012 S$1.96 M-95.73%
2011 S$45.96 M
2009 -S$64.62 Million-45.38%
2008 -S$0.12 Billion-58.87%
2007 -S$0.29 Billion87.3%
2006 -S$0.16 Billion351.97%
2005 -S$33.98 Million-52.09%
2004 -S$70.92 Million-10.98%
2003 -S$79.67 Million
2001 -S$59.47 Million
1999 -S$26.82 Million108.32%
1998 -S$12.88 Million
1996 S$3.92 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$26.04 M-97.07%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.60 B 192.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
-S$43.83 Million-104.92%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.75 B 1,445.68%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.75 B 995.93%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.40 B 957.26%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$10.17 Million-101.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$56.6 Million-106.36%๐Ÿ‡บ๐Ÿ‡ธ USA